The June issue of ACS Infectious Diseases: dedicated to AMR challenges

The June issue of ACS Infectious Diseases is a special issue on antibiotics featuring all major stakeholders and perspectives in the AMR community.

The June issue of ACS Infectious Diseases is a special issue on antibiotics featuring many different perspectives on how the antibiotic ecosystem can be restored and maintained. Included are many perspectives from major groups driving policy, groups doing active R&D, and the major funders.

In his newsletter John Rex has provided a good overview of the content, slightly re-organized by topic. All articles appear to be open access:

Overviews & Policy work:
- Blaskovich: Antibiotics Special Issue: Challenges and Opportunities in Antibiotic Discovery and Development
- Beyer and Paulin (WHO): The Antibacterial Research and Development Pipeline Needs Urgent Solutions
- Kim, Prosen, Lepore, and Coukell (Pew Trusts): On the Road to Discovering Urgently Needed Antibiotics: So Close Yet So Far Away
- Wiecek and Buckland-Merritt (Wellcome Trust): A View from the Wellcome Trust Drug-Resistant Infections Priority Programme: Creating a Sustainable Research and Development Ecosystem to Meet the Global Need for Antibiotics
- Shlaes: Antibacterial Drugs: The Last Frontier and Personal View of the Antibiotic Value Proposition
Action:
- Balasegaram and Piddock (GARDP): The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development
- Zuegg, Hansford, Elliott, Cooper, and Blaskovich (CO-ADD): How to Stimulate and Facilitate Early Stage Antibiotic Discovery
- Nambiar (FDA), Cavaleri (EMA), Sato (PMDA): Achieving Regulatory Alignment for Anti-Infective Clinical Trials
R&D Support:
- Zeituni and Raterman (NIAID): NIAID’s Comprehensive Support Mechanisms for Antibiotic Development
- Engel (Novo REPAIR Impact Fund): Fostering Antibiotic Development through Impact Funding
- Alm & Gallant: Innovation in Antimicrobial Resistance: The CARB-X Perspective